Article
Clonal diversity analysis using SNP microarray: a new prognostic tool for chronic lymphocytic leukemia.
Cancer genetics - 1 Dec 2011
Zhang Linsheng, Znoyko Iya, Costa Luciano J, Conlin Laura K, Daber Robert D, Self Sally E, Wolff Daynna J
Abstract excerpt
Chronic lymphocytic leukemia (CLL) is a clinically heterogeneous disease. The methods currently used for monitoring CLL and determining conditions for treatment are limited in their ability to predict disease progression, patient survival, and response to therapy. Although clonal diversity and th...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
